Rapid Remission With Upadacitinib in a Child With Refractory Crohn's Disease and ATM Mutation: A Case Report
ABSTRACT: Managing pediatric Crohn's disease (PCD) presents challenges due to severe complications and higher biologic therapy needs. Transitioning from anti–tumor necrosis factor agents to off-label therapies adds complexity. Although upadacitinib has demonstrated efficacy and tolerability in adult...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2024-01-01
|
| Colección: | Current Therapeutic Research |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S0011393X24000262 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|